Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$499.74 -9.01 (-1.77%)
At close: Oct 16, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Gross Profit (2010 - 2026)

Updated

Vertex Pharmaceuticals' Gross Profit came in at $2.84 billion for Q2 2026, up 11.2% from $2.56 billion a year earlier and up 9.7% from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Gross Profit (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Vertex Pharmaceuticals reported Gross Profit of $10.82 billion, up 10.1% year-over-year; for FY2025, it came in at $10.35 billion, up 9.1% from FY2024.

  • Gross Profit has increased in each of the last 11 years, with a five-year compound annual growth rate of 13.6% (FY2020 to FY2025).
  • Going back by year, Gross Profit was $9.49 billion in FY2024 (+10.3%), $8.61 billion in FY2023 (+9.6%), $7.85 billion in FY2022 (+17.7%) and $6.67 billion in FY2021 (+22.0%).
  • The Q2 2026 figure represents the highest quarterly Gross Profit in data going back to Q2 2010.
  • Year-over-year, Gross Profit has increased for 33 consecutive quarters, with growth averaging 10.1% over the last eight quarters.
  • Across the past five years, year-over-year growth in Gross Profit ran from 2.5% in Q1 2025 to 29.3% in Q3 2021.
  • Business Quant data shows VRTX's Gross Profit at $2.59 billion (Q1 2026), $2.72 billion (Q4 2025) and $2.66 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
API Access

Vertex Pharmaceuticals Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=VRTX&period=max&api_key=YOUR_API_KEY